Sequential vaccination against influenza and COVID-19, and innate immunity indexes: efficiency aspects
- Authors: Li Y.A.1, Dmitrachenko M.N.1, Markelova E.V.1, Kostinov M.P.2,3, Korolev I.B.1, Kovalchuk V.K.1, Yamilova O.Y.1, Nemtseva I.Y.1
-
Affiliations:
- Pacific State Medical University
- I. Mechnikov Research Institute of Vaccines and Sera
- I. Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 28, No 1 (2025)
- Pages: 83-90
- Section: SHORT COMMUNICATIONS
- URL: https://ogarev-online.ru/1028-7221/article/view/277346
- DOI: https://doi.org/10.46235/1028-7221-16990-SVA
- ID: 277346
Cite item
Full Text
Abstract
Evaluation of cytokine dynamics during vaccination is an important aspect in assessing the vaccine preventive efficiency and personalized approach to combined vaccination. Our aim was to study the impact of influenza and COVID-19 vaccination on innate immunity in young patients by assessing the time-related changes of cytokine profile.
The study group included 76 young adults of 19 years old. The cytokine contents were studied in venous blood sera by enzyme immunoassay. The first series of blood samples was taken before influenza vaccination; the second sampling was performed 1 month after influenza vaccination and before COVID-19 vaccination; the third series was carried out 1 month after COVID-19 vaccination and 2 months after influenza vaccination. The results were processed by Statistica-10 and SPSS v. 20 software. The vaccinated persons were monitored for 6 months after vaccination.
IL-8, IL-17 levels before vaccination were above normal in 100% of subjects; IL-6, in 76% of cases. IL- 1â, IL-4 and IL-10 levels were under normal levels in more than 50% of cases. After influenza vaccination, a significant decrease in cytokine levels was observed: IL-1â comtet was below normal values in 89%; IL-4, in 100% of cases, as well as IL-6 (in 79%), IL-8 (in 74%), IL-10 (in 89%), IFNã (in 63%), TNFá (in 76%), and only IL-17 was within normal ranges in 72% of cases. After vaccination against COVID-19 and influenza, a more rapid decrease in cytokine levels was observed: IL-1â was below baseline values in 95%, IL-6, IL-8, IFNã and TNFá were reduced in 100%; IL-10, in 90% of cases, along with normalization of anti-inflammatory IL-4 cytokine. Despite a significant decrease of the indexes, we revealed multiple strong multidirectional correlations between the cytokine contents, being especially significant between IL-1â, IL-6, and IL-8. During 6-mo observation after vaccination, two cases of COVID-19 (2.6%) were documented and confirmed by PCR test. No influenza cases have been detected over this period.
At the begining of the study, a favorable cytokine background for effective vaccination was observed. After vaccination against COVID-19 and influenza, a decrease of the pro- and anti-inflammatory cytokine levels was recorded, and strong correlations were found, thus suggesting an increase in the immune response following vaccination. The changes of IL-1â, IL-6, IL-8 were most remarkable at all stages of vaccination.
Full Text
##article.viewOnOriginalSite##About the authors
Y. A. Li
Pacific State Medical University
Author for correspondence.
Email: julianochka160188@gmail.com
PhD (Medicine), Clinical Infectiologist, Major of Medical Service, Lecturer, Military Training Center
Russian Federation, VladivostokM. N. Dmitrachenko
Pacific State Medical University
Email: julianochka160188@gmail.com
Student, Medical Faculty
Russian Federation, VladivostokE. V. Markelova
Pacific State Medical University
Email: julianochka160188@gmail.com
PhD, MD (Medicine), Professor, Head, Department of Normal and Pathological Physiology
Russian Federation, VladivostokM. P. Kostinov
I. Mechnikov Research Institute of Vaccines and Sera; I. Sechenov First Moscow State Medical University (Sechenov University)
Email: julianochka160188@gmail.com
PhD, MD (Medicine), Professor, Corresponding Member, Russian Academy of Sciences, Head, Laboratory of Vaccination and Immunotherapy of Allergic Diseases, Head, Department of Epidemiology and Modern Technologies of Vaccination
Russian Federation, Moscow; MoscowI. B. Korolev
Pacific State Medical University
Email: korolev@tgmu.ru
PhD (Medicine), Colonel of Medical Service, Head, Military Training Center
VladivostokV. K. Kovalchuk
Pacific State Medical University
Email: julianochka160188@gmail.com
PhD, MD (Medicine), Professor
Russian Federation, VladivostokO. Y. Yamilova
Pacific State Medical University
Email: julianochka160188@gmail.com
PhD (Medicine), Associate Professor
Russian Federation, VladivostokIrina Y. Nemtseva
Pacific State Medical University
Email: julianochka160188@gmail.com
Student, Medical Faculty
Russian Federation, VladivostokReferences
- Заплатников А.Л., Бурцева Е.И., Гирина А.А., Свинцицкая В.И., Леписева И.В. Активная специфическая иммунопрофилактика гриппа в условиях пандемии COVID-19 и начало вакцинации против коронавирусной инфекции, вызванной вирусом SARS-CoV-2 // Педиатрия. Приложение к журналу Consilium Medicum, 2020. № 4. С. 12-16. [Zaplatnikov A.L., Burtseva E.I., Girina A.A., Svintsitskaya V.I., Lepiseva I.V. Active specific immunoprevention of influenza during the COVID-19 pandemic and the start of vaccination against coronavirus infection caused by the SARS-CoV-2 virus. Pediatriya. Prilozhenie k zhurnalu Consilium Medicum = Pediatrics. Supplement to the Journal Consilium Medicum, 2020, no. 4, pp. 12-16. (In Russ.)]
- Костинов М.П. Свитич О.А., Маркелова Е.В. Потенциальная иммунопрофилактика COVID-19 у групп высокого риска инфицирования. Временное пособие для врачей. М.: Группа МДВ, 2020. 64 с. [Kostinov M.P. Svitich O.A., Markelova E.V. Potential immunoprophylaxis of COVID-19 in groups at high risk of infection. Temporary allowance for doctors]. Moscow: MDV Group, 2020, 64 p.
- Костинов М.П., Хромова Е.А., Костинова А.М. Может ли вакцинация против гриппа быть неспецифической профилактикой SARS-COV-2 и других респираторных инфекций? // Инфекционные болезни: новости, мнения, обучение, 2020. Т. 9, № 3. С. 36-40. [Kostinov M.P., Khromova E.A., Kostinova A.M. Can influenza vaccination be a nonspecific prevention of SARS-COV-2 and other respiratory infections? Infektsionnye bolezni: novosti, mneniya, obuchenie = Infectious Diseases: News, Opinions, Training, 2020, Vol. 9, no. 3, pp. 36-40. (In Russ.)]
- Крылова Н.В., Леонова Г.Н., Павленко Е.В. Особенности цитокинового профиля на ранних стадиях инфицирования вирусом клещевого энцефалита у вакцинированных и невакцинированных людей // Тихоокеанский медицинский журнал, 2012. № 4. C. 78-81. [Krylova N.V., Leonova G.N., Pavlenko E.V. Features of the cytokine profile in the early stages of infection with tick-borne encephalitis virus in vaccinated and unvaccinated people. Tikhookeanskiy meditsinskiy zhurnal = Pacific Medical Journal, 2012, no. 4, pp. 78-81. (In Russ.)]
- Лазарева И.А., Орлова С.Н., Дудник О.В. Влияние вакцинации против гриппа на заболеваемость, смертность и тяжесть течения новой коронавирусной инфекции // Вестник ИвГМА, 2022. Т. 27, № 1. C. 47-50. [Lazareva I.A., Orlova S.N., Dudnik O.V. Influence vaccination on mortality, mortality and severity of new coronavirus infection. Vestnik IvGMA = Bulletin of IvSMA, 2022, Vol. 27, no. 1, pp. 47-50. (In Russ.)]
- Мамаев А.Н. Основы медицинской статистики. М.: Практическая медицина, 2011. 121 с. [Mamaev A.N. Fundamentals of medical statistics]. Moscow: Prakticheskaya meditsina, 2011, 121 p.
- Садыков В.Ф., Полтавцева Р.А., Чаплыгина А.В., Бобкова Н.В. Иммунный статус и спектр цитокинов как прогностические признаки риска тяжелого течения заболевания и эффективности интенсивной терапии пациентов с коронавирусной инфекцией COVID-19 // Анализ риска здоровью, 2022. № 4. C. 148-158. [Sadykov V.F., Poltavtseva R.A., Chaplygina A.V., Bobkova N.V. Immune status and spectrum of cytokines as prognostic signs of the risk of severe disease and the effectiveness of intensive care in patients with coronavirus infection COVID-19. Analiz riska zdorovyu = Health Risk Analysis, 2022, no. 4, pp. 148-158. (In Russ.)]
- Хаитов Р.М. Руководство по клинической иммунологии. Диагностика заболеваний иммунной системы. М.: ГЭОТАР-Медиа, 2009. 352 с. [Khaitov R.M. Manual of Clinical Immunology. Diagnosis of immune system diseases]. Moscow: GEOTAR-Media, 2009. 352 p.
- Хасанова Г.Р., Малинина Л.А., Ильина О.А. Эффективность вакцинации от COVID-19: результаты исследования «случай-контроль» // Медицинский альманах, 2023. Т. 76, № 3. C. 55-62. [Khasanova G.R., Malinina L.A., Ilyina O.A. Effectiveness of vaccination against COVID-19: results of a case-control study. Meditsinskiy almanakh = Medical Almanac, 2023, Vol. 76, no. 3, pp. 55-62. (In Russ.)]
- Achdout H., Vitner E.B., Politi B., Melamed S., Yahalom-Ronen Y., Tamir H., Erez N., Avraham R., Weiss S., Cherry L., Bar-Haim E., Makdasi E., Gur D., Aftalion M., Chitlaru T., Vagima Y., Paran N., Israely T. Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity. Nat. Commun., 2021, Vol. 12, 5819. doi: 10.1038/s41467-021-26113-1.
- Lu D., Han Y., Xu R., Qin M., Shi J., Zhang C., Zhang J., Ye F., Luo Z., Wang Y., Wang C., Wang C. Evaluation of the efficacy, safety and influencing factors of concomitant and sequential administration of viral respiratory infectious disease vaccines: a systematic review and meta-analysis. Front. Immunol., 2023, Vol. 14, 1259399. doi: 10.3389/fimmu.2023.1259399.
Supplementary files
